drugset / Trial / NCT05752903

Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation of CT Guided Bone Biopsy

NCT05752903 ↗

Phase 4 Completed 60 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to compare the effectiveness and safety of a dexmedetomidine-propofol combination and a ketamine-Propofol combination for sedation of CT guided bone biopsy.

Timeline

Start
2023-03-04
Primary completion
2023-09-10
Completion
2023-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Ketamine Small molecule 0.25 mg/kg Intravenous
Comparator Propofol Small molecule 2.5 mg/kg Intravenous

Indications

No indication recorded.